Distribution Agreement Signed with Novartis

Advanced Medical Solutions Grp PLC 6 April 2000 ADVANCED MEDICAL SOLUTIONS GROUP PLC SIGNS DISTRIBUTION AGREEMENT WITH NOVARTIS CONSUMER HEALTH Winsford, 6 April 2000: Advanced Medical Solutions Group plc (AMS), today announced the signing of an agreement with Novartis Consumer Health, Europe, for the distribution of its ActivHeal(TM) range of innovative wound dressings into the third largest consumer healthcare market, Germany. This is the second such agreement with Novartis Consumer Health; in January of this year a similar agreement covering UK and Ireland was signed. AMS now has distribution in the majority of the key world-wide consumer healthcare markets. Commenting on the agreement, Don Evans, Chief Executive of AMS, said: 'We are very pleased with this extension of our association with Novartis Consumer Health; their continued interest confirms the leadership position AMS has established developing the market for advanced First Aid products.' Michael Orsinger, Regional Director of Europe, Novartis Consumer Health, added: 'We are delighted to be able to add the advanced first aid range of woundcare products to the Fenistil brand in Germany and look forward to developing further our relationship with AMS.' Advanced Medical Solutions is one of the leading global companies in the development and manufacture of products for the advanced wound-care market which is currently estimated to be in excess of US$1 billion world-wide (1999). Novartis is a world leader in healthcare with core businesses in pharmaceuticals, consumer health, generics, eye-care, and animal health. In 1999, the Group (including Agribusiness) achieved sales of CHF 32.4 billion. Enquiries: Advanced Medical Solutions Group plc Don Evans, Chief Executive Officer Tel: 01606 863500 Mary Tavener, Group Finance Director Gavin Anderson & Co Philip Ward / Charlotte Stone Tel: 0171 457 2345 Further information on Advanced Medical Solutions can be found at www.admedsol.com
UK 100

Latest directors dealings